BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Keller DS, Windsor A, Cohen R, Chand M. Colorectal cancer in inflammatory bowel disease: review of the evidence. Tech Coloproctol 2019;23:3-13. [PMID: 30701345 DOI: 10.1007/s10151-019-1926-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 14.7] [Reference Citation Analysis]
Number Citing Articles
1 Rizopoulos T, Assimakopoulou M. Transient receptor potential (TRP) channels in human colorectal cancer: evidence and perspectives. Histol Histopathol 2021;36:515-26. [PMID: 33528023 DOI: 10.14670/HH-18-308] [Reference Citation Analysis]
2 Patel G, Patil P. Worrisome Trends in Young-Onset Colorectal Cancer: Now Is the Time for Action. Indian J Surg Oncol. [DOI: 10.1007/s13193-022-01496-9] [Reference Citation Analysis]
3 Ternet C, Kiel C. Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage. Cell Commun Signal 2021;19:31. [PMID: 33691728 DOI: 10.1186/s12964-021-00712-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 James S, Aparna JS, Babu A, Paul AM, Lankadasari MB, Athira SR, Kumar SS, Vijayan Y, Namitha NN, Mohammed S, Reshmi G, Harikumar KB. Cardamonin Attenuates Experimental Colitis and Associated Colorectal Cancer. Biomolecules 2021;11:661. [PMID: 33947113 DOI: 10.3390/biom11050661] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Ali Khan U, Fallah M, Tian Y, Sundquist K, Sundquist J, Brenner H, Kharazmi E. Personal History of Diabetes as Important as Family History of Colorectal Cancer for Risk of Colorectal Cancer: A Nationwide Cohort Study. Am J Gastroenterol 2020;115:1103-9. [PMID: 32618661 DOI: 10.14309/ajg.0000000000000669] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
6 Tao J, Tu Y, Liu P, Tang Y, Wang F, Li Z, Li C, Li Y, Ma Y, Gu Y. Detection of colorectal cancer using a small molecular fluorescent probe targeted against c-Met. Talanta 2021;226:122128. [DOI: 10.1016/j.talanta.2021.122128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Silvestri C, Pagano E, Lacroix S, Venneri T, Cristiano C, Calignano A, Parisi OA, Izzo AA, Di Marzo V, Borrelli F. Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis. Front Pharmacol 2020;11:585096. [PMID: 33162890 DOI: 10.3389/fphar.2020.585096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Baritaki S, de Bree E, Chatzaki E, Pothoulakis C. Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular Crosstalk. J Clin Med 2019;8:E1669. [PMID: 31614860 DOI: 10.3390/jcm8101669] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
9 Ibáñez Vodnizza SE, De La Fuente MPP, Parra Cancino EC. Approach to the Patient with Axial Spondyloarthritis and Suspected Inflammatory Bowel Disease. Rheum Dis Clin North Am 2020;46:275-86. [PMID: 32340701 DOI: 10.1016/j.rdc.2020.01.004] [Reference Citation Analysis]
10 Taylor CC, Millien VO, Hou JK, Massarweh NN. Association Between Inflammatory Bowel Disease and Colorectal Cancer Stage of Disease and Survival. J Surg Res 2020;247:77-85. [PMID: 31767275 DOI: 10.1016/j.jss.2019.10.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 Ali Khan U, Fallah M, Sundquist K, Sundquist J, Brenner H, Kharazmi E. Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study. PLoS Med. 2020;17:e1003431. [PMID: 33186354 DOI: 10.1371/journal.pmed.1003431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
12 Arhi C, Askari A, Nachiappan S, Bottle A, Arebi N, Athanasiou T, Ziprin P, Aylin P, Faiz O. Stage at Diagnosis and Survival of Colorectal Cancer With or Without Underlying Inflammatory Bowel Disease: A Population-based Study. Journal of Crohn's and Colitis 2021;15:375-82. [DOI: 10.1093/ecco-jcc/jjaa196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Choe MY, Wright R, Parian A. Follow-up Care in Inflammatory Bowel Disease: An Integrative Review. Gastroenterol Nurs 2021;44:E48-R58. [PMID: 34037572 DOI: 10.1097/SGA.0000000000000570] [Reference Citation Analysis]
14 Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, Bernstein CN, Danese S, Peyrin-Biroulet L, Hibi T. Ulcerative colitis.Nat Rev Dis Primers. 2020;6:74. [PMID: 32913180 DOI: 10.1038/s41572-020-0205-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 26.0] [Reference Citation Analysis]
15 You YN, Lee LD, Deschner BW, Shibata D. Colorectal Cancer in the Adolescent and Young Adult Population. JCO Oncol Pract 2020;16:19-27. [PMID: 32039664 DOI: 10.1200/JOP.19.00153] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Jia W, He YF, Qian XJ, Chen J. TPMT mRNA Expression: A Novel Prognostic Biomarker for Patients with Colon Cancer by Bioinformatics Analysis. Int J Gen Med 2022;15:151-60. [PMID: 35023953 DOI: 10.2147/IJGM.S338575] [Reference Citation Analysis]
17 Rombouts AJM, Hugen N, Elferink MAG, Poortmans PMP, Nagtegaal ID, de Wilt JHW. Increased risk for second primary rectal cancer after pelvic radiation therapy. Eur J Cancer 2020;124:142-51. [PMID: 31765989 DOI: 10.1016/j.ejca.2019.10.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
18 Zhou Q, Shen ZF, Wu BS, Xu CB, He ZQ, Chen T, Shang HT, Xie CF, Huang SY, Chen YG, Chen HB, Han ST. Risk of Colorectal Cancer in Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract 2019;2019:5363261. [PMID: 31781191 DOI: 10.1155/2019/5363261] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
19 Li J, Zhang Y, Xu Q, Wang G, Jiang L, Wei Q, Luo C, Chen L, Ying J. Systemic Inflammatory Markers of Resectable Colorectal Cancer Patients with Different Mismatch Repair Gene Status. Cancer Manag Res 2021;13:2925-35. [PMID: 33833576 DOI: 10.2147/CMAR.S298885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Nam SH, Kim JK. Tussilagone Reduces Tumorigenesis by Diminishing Inflammation in Experimental Colitis-Associated Colon Cancer. Biomedicines 2020;8:E86. [PMID: 32290483 DOI: 10.3390/biomedicines8040086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Moughnyeh MM, Brawner KM, Kennedy BA, Yeramilli VA, Udayakumar N, Graham JA, Martin CA. Stress and the Gut-Brain Axis: Implications for Cancer, Inflammation and Sepsis. J Surg Res 2021;266:336-44. [PMID: 34062291 DOI: 10.1016/j.jss.2021.02.055] [Reference Citation Analysis]
22 Flores E, Mbachi C, Achebe I, Asotibe J, Palomera-Tejeda E, Vohra I, Udechukwu V, Kotwal V. Temporal trend in inpatient mortality in inflammatory bowel disease-associated colorectal cancer vs non-inflammatory colorectal cancer: a nationwide retrospective study. Int J Colorectal Dis 2021;36:701-8. [PMID: 33063223 DOI: 10.1007/s00384-020-03775-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Zhou N, Zhao Y, Yao Y, Wu N, Xu M, Du H, Wu J, Tu Y. Antioxidant Stress and Anti-Inflammatory Activities of Egg White Proteins and Their Derived Peptides: A Review. J Agric Food Chem 2021. [PMID: 34962122 DOI: 10.1021/acs.jafc.1c04742] [Reference Citation Analysis]
24 Prados ME, García-Martín A, Unciti-Broceta JD, Palomares B, Collado JA, Minassi A, Calzado MA, Appendino G, Muñoz E. Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease. Acta Pharmacol Sin 2021;42:1124-38. [PMID: 32811965 DOI: 10.1038/s41401-020-0497-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Zu M, Xie D, Canup BSB, Chen N, Wang Y, Sun R, Zhang Z, Fu Y, Dai F, Xiao B. 'Green' nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases. Biomaterials 2021;279:121178. [PMID: 34656857 DOI: 10.1016/j.biomaterials.2021.121178] [Reference Citation Analysis]
26 Ohnishi S, Hiramoto K, Ma N, Kawanishi S. Chemoprevention by aspirin against inflammation-related colorectal cancer in mice. J Clin Biochem Nutr 2021;69:265-71. [PMID: 34857988 DOI: 10.3164/jcbn.20-189] [Reference Citation Analysis]
27 Hikisz P, Bernasinska-Slomczewska J. Beneficial Properties of Bromelain. Nutrients 2021;13:4313. [PMID: 34959865 DOI: 10.3390/nu13124313] [Reference Citation Analysis]
28 Loke YL, Chew MT, Ngeow YF, Lim WWD, Peh SC. Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota. Front Cell Infect Microbiol 2020;10:603086. [PMID: 33364203 DOI: 10.3389/fcimb.2020.603086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
29 Cutone A, Ianiro G, Lepanto MS, Rosa L, Valenti P, Bonaccorsi di Patti MC, Musci G. Lactoferrin in the Prevention and Treatment of Intestinal Inflammatory Pathologies Associated with Colorectal Cancer Development. Cancers (Basel) 2020;12:E3806. [PMID: 33348646 DOI: 10.3390/cancers12123806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 2021;6:263. [PMID: 34248142 DOI: 10.1038/s41392-021-00658-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Azizmohammad Looha M, Zarean E, Masaebi F, Pourhoseingholi MA, Zali MR. Assessment of prognostic factors in long-term survival of male and female patients with colorectal cancer using non-mixture cure model based on the Weibull distribution. Surg Oncol 2021;38:101562. [PMID: 33862578 DOI: 10.1016/j.suronc.2021.101562] [Reference Citation Analysis]
32 Pellino G, Keller DS, Sampietro GM, Annese V, Carvello M, Celentano V, Coco C, Colombo F, Cracco N, Di Candido F, Franceschi M, Laureti S, Mattioli G, Pio L, Sciaudone G, Sica G, Villanacci V, Zinicola R, Leone S, Danese S, Spinelli A, Delaini G, Selvaggi F;  the Italian Society of Colorectal Surgery (SICCR). Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management. Tech Coloproctol. 2020;24:105-126. [PMID: 31983044 DOI: 10.1007/s10151-019-02145-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
33 Kim J, Lee J, Oh JH, Chang HJ, Sohn DK, Shin A, Kim J. Plasma inflammatory biomarkers and modifiable lifestyle factors associated with colorectal cancer risk. Clin Nutr 2020;39:2778-85. [PMID: 31883943 DOI: 10.1016/j.clnu.2019.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
34 Solis E, Reza F, Toh JWT, El-Khoury T. Anorectal cancer in Crohn's disease: a rare entity. ANZ J Surg 2021;91:E223-4. [PMID: 32846038 DOI: 10.1111/ans.16286] [Reference Citation Analysis]
35 Morsy MA, Khalaf HM, Rifaai RA, Bayoumi AMA, Khalifa EMMA, Ibrahim YF. Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2. Biomed Pharmacother 2021;141:111902. [PMID: 34328119 DOI: 10.1016/j.biopha.2021.111902] [Reference Citation Analysis]
36 Zhang LZ, Xue H, Qiao CX, You WL, Di AT, Zhao G. MiR-223 promotes pyroptosis of enteritis cells through activating NF-κB signalling pathway by targeting SNIP1 in inflammatory bowel disease. Autoimmunity 2021;54:362-72. [PMID: 34151668 DOI: 10.1080/08916934.2021.1940973] [Reference Citation Analysis]
37 Kehm RD, McDonald JA, Fenton SE, Kavanaugh-Lynch M, Leung KA, McKenzie KE, Mandelblatt JS, Terry MB. Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research. Int J Environ Res Public Health 2020;17:E5445. [PMID: 32731638 DOI: 10.3390/ijerph17155445] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
38 Vitello A, Shahini E, Macaluso FS, Morreale GC, Sinagra E, Pallio S, Maida M. Endoscopic surveillance of colorectal cancer in inflammatory bowel diseases: a review of the literature. Expert Rev Anticancer Ther 2020;20:851-63. [PMID: 32811225 DOI: 10.1080/14737140.2020.1813030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
39 Ye GY, Zhang ZZ, Zhu CC, Cong ZJ, Cui Z, Chen L, Zhao G. Long Non-Coding RNA LINC01569 Promotes Proliferation and Metastasis in Colorectal Cancer by miR-381-3p/RAP2A Axis. Front Oncol 2021;11:727698. [PMID: 34422671 DOI: 10.3389/fonc.2021.727698] [Reference Citation Analysis]
40 Sun Y, Diao F, Niu Y, Li X, Zhou H, Mei Q, Li Y. Apple polysaccharide prevents from colitis-associated carcinogenesis through regulating macrophage polarization. Int J Biol Macromol 2020;161:704-11. [PMID: 32544579 DOI: 10.1016/j.ijbiomac.2020.06.121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 D'Antongiovanni V, Fornai M, Pellegrini C, Benvenuti L, Blandizzi C, Antonioli L. The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia. Int J Mol Sci 2020;21:E5089. [PMID: 32708507 DOI: 10.3390/ijms21145089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
42 Shi JL, Lv YH, Huang J, Huang X, Liu Y. Patients with inflammatory bowel disease and post-inflammatory polyps have an increased risk of colorectal neoplasia: A meta-analysis. World J Clin Cases 2022; 10(3): 966-984 [DOI: 10.12998/wjcc.v10.i3.966] [Reference Citation Analysis]
43 Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, Przybyłowicz KE. A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers (Basel) 2021;13:2025. [PMID: 33922197 DOI: 10.3390/cancers13092025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
44 Brar MS, de Buck van Overstraeten A, Baxter NN. Rectal Cancer Incidence is Low Following Rectal Diversion or Subtotal Colectomy for IBD: Results of a Population-based Study. J Crohns Colitis 2021:jjab090. [PMID: 34165532 DOI: 10.1093/ecco-jcc/jjab090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Geng Z, Geng Q. Risk of Urinary Bladder Cancer in Patients With Inflammatory Bowel Diseases: A Meta-Analysis. Front Surg 2021;8:636791. [PMID: 34124132 DOI: 10.3389/fsurg.2021.636791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Nehme F, Schneider A, Hamid F. Appendiceal Adenocarcinoma Associated With Ulcerative Colitis. ACG Case Rep J 2019;6:e00255. [PMID: 32309470 DOI: 10.14309/crj.0000000000000255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
47 Zhang F, Qiao S. Research Progress on the Relationship Between Inflammation and Colorectal Cancer. Ann Gastroenterol Surg. [DOI: 10.1002/ags3.12517] [Reference Citation Analysis]
48 Keshavarz Shahbaz S, Koushki K, Ayati SH, Bland AR, Bezsonov EE, Sahebkar A. Inflammasomes and Colorectal Cancer. Cells 2021;10:2172. [PMID: 34571825 DOI: 10.3390/cells10092172] [Reference Citation Analysis]
49 Kobayashi M, Matsubara N, Nakachi Y, Okazaki Y, Uchino M, Ikeuchi H, Song J, Kimura K, Yasuhara M, Babaya A, Yamano T, Ikeda M, Nishikawa H, Matsuda I, Hirota S, Tomita N. Hypermethylation of Corticotropin Releasing Hormone Receptor-2 Gene in Ulcerative Colitis Associated Colorectal Cancer. In Vivo 2020;34:57-63. [PMID: 31882463 DOI: 10.21873/invivo.11745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Nugent TS, Low EZ, Fahy MR, Donlon NE, Mccormick PH, Mehigan BJ, Cunningham M, Gillham C, Kavanagh DO, Kelly ME, Larkin JO. Prostate radiotherapy and the risk of secondary rectal cancer—a meta-analysis. Int J Colorectal Dis. [DOI: 10.1007/s00384-021-04075-6] [Reference Citation Analysis]
51 Dhillon VS, Deo P, Bonassi S, Fenech M. Lymphocyte micronuclei frequencies in skin, haematological, prostate, colorectal and esophageal cancer cases: A systematic review and meta-analysis. Mutat Res Rev Mutat Res 2021;787:108372. [PMID: 34083057 DOI: 10.1016/j.mrrev.2021.108372] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Villanacci V, Reggiani-Bonetti L, Caprioli F, Saragoni L, Salviato T, Mescoli C, Canavese G, Manenti S, Spada E, Baron L, Leoncini G, Cadei M, Battista S, Armuzzi A. Histopathology of inflammatory bowel disease - Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC). Dig Liver Dis 2020;52:262-7. [PMID: 31884010 DOI: 10.1016/j.dld.2019.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
53 Couvineau A, Voisin T, Nicole P, Gratio V, Blais A. Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol 2021; 27(44): 7582-7596 [PMID: 34908800 DOI: 10.3748/wjg.v27.i44.7582] [Reference Citation Analysis]
54 Kudelka MR, Stowell SR, Cummings RD, Neish AS. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD. Nat Rev Gastroenterol Hepatol. 2020;17:597-617. [PMID: 32710014 DOI: 10.1038/s41575-020-0331-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
55 Musa M, Ali A. Cancer-associated fibroblasts of colorectal cancer and their markers: updates, challenges and translational outlook. Future Oncol 2020;16:2329-44. [PMID: 32687721 DOI: 10.2217/fon-2020-0384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Magro F, Estevinho MM. Is tofacitinib a game-changing drug for ulcerative colitis? United European Gastroenterol J 2020;8:755-63. [PMID: 32552501 DOI: 10.1177/2050640620935732] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
57 Lee JG, Lee S, Jeon J, Kong HG, Cho HJ, Kim JH, Kim SY, Oh MJ, Lee D, Seo N, Park KH, Yu K, An HJ, Ryu CM, Lee JS. Host tp53 mutation induces gut dysbiosis eliciting inflammation through disturbed sialic acid metabolism. Microbiome 2022;10:3. [PMID: 34991725 DOI: 10.1186/s40168-021-01191-x] [Reference Citation Analysis]